Scleroderma Treatment News and Information

What is Scleroderma? (Definition)

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Scleroderma is a group of diseases that affect connective tissue in the body. This tissue supports your skin and internal organs. Scleroderma involves tissue that gets hard or thick. It can also cause swelling or pain in the muscles and joints.

Scleroderma’s main types are localized and systemic. Localized means the disease affects only certain parts of the body. Systemic means it can affect the whole body.

The localized type often affects only skin tissues. It does not harm major organs. It may get better or go away without help. But it can be severe in some people and can leave skin damage.

The systemic type affects the skin, tissues under it, blood vessels, and major organs.

See below for updated news and information regarding Scleroderma including new medical research, treatment options and advancements. 

Latest Scleroderma Treatment News and Research


(SOURCE: MICHIGAN STATE UNIVERSITY) - Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule drug compound goes after a gene’s ability to produce RNA molecules and certain proteins in melanoma tumors. This gene activity, or transcription process, causes the disease to spread ...
Read More

Scleroderma Research News: Gene activity predicts progression of autoimmune disease, researchers find

(SOURCE: STANFORD UNIVERSITY MEDICAL CENTER) - Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could. Researchers at the Stanford University School of Medicine and six other institutions have designed a new diagnostic tool for a rare and deadly autoimmune disease that affects ...
Read More